Annual ROE
-33.53%
-62.92%-214.09%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual return on equity is -33.53%, with the most recent change of -62.92% (-214.09%) on December 31, 2023.
- During the last 3 years, VIR annual ROE has risen by +18.83% (+35.96%).
- VIR annual ROE is now -133.08% below its all-time high of 101.36%, reached on December 31, 2017.
Performance
VIR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-35.62%
-5.64%-18.81%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly return on equity is -35.62%, with the most recent change of -5.64% (-18.81%) on September 30, 2024.
- Over the past year, VIR quarterly ROE has dropped by -5.64% (-18.81%).
- VIR quarterly ROE is now -105.06% below its all-time high of 703.88%, reached on September 30, 2019.
Performance
VIR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VIR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -214.1% | -18.8% |
| 3 y3 years | +36.0% | -403.1% |
| 5 y5 years | -151.8% | -403.1% |
VIR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -168.2% | at low | -133.4% | at low |
| 5 y | 5-year | -168.2% | +76.5% | -133.4% | +81.4% |
| alltime | all time | -133.1% | +76.5% | -105.1% | +81.4% |
Vir Biotechnology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -35.62%(+18.8%) |
| Jun 2024 | - | -29.98%(-4.5%) |
| Mar 2024 | - | -31.39%(-6.9%) |
| Dec 2023 | -33.53%(-214.1%) | -33.70%(+8.7%) |
| Sep 2023 | - | -31.01%(+135.8%) |
| Jun 2023 | - | -13.15%(+85.7%) |
| Mar 2023 | - | -7.08%(-126.4%) |
| Dec 2022 | 29.39%(-40.3%) | 26.83%(-60.5%) |
| Sep 2022 | - | 67.93%(-11.8%) |
| Jun 2022 | - | 77.00%(-27.9%) |
| Mar 2022 | - | 106.73%(+78.2%) |
| Dec 2021 | 49.20% | 59.89%(-544.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -13.49%(-68.4%) |
| Jun 2021 | - | -42.71%(-31.6%) |
| Mar 2021 | - | -62.47%(+21.2%) |
| Dec 2020 | -52.36%(-63.3%) | -51.54%(-23.7%) |
| Sep 2020 | - | -67.59%(-8.7%) |
| Jun 2020 | - | -74.05%(-50.5%) |
| Mar 2020 | - | -149.68%(-21.7%) |
| Dec 2019 | -142.74%(-320.7%) | -191.21%(-127.2%) |
| Sep 2019 | - | 703.88%(-738.8%) |
| Jun 2019 | - | -110.18%(-323.0%) |
| Mar 2019 | - | 49.40%(+47.9%) |
| Dec 2018 | 64.68%(-36.2%) | 33.40% |
| Dec 2017 | 101.36% | - |
FAQ
- What is Vir Biotechnology annual return on equity?
- What is the all time high annual ROE for Vir Biotechnology?
- What is Vir Biotechnology annual ROE year-on-year change?
- What is Vir Biotechnology quarterly return on equity?
- What is the all time high quarterly ROE for Vir Biotechnology?
- What is Vir Biotechnology quarterly ROE year-on-year change?
What is Vir Biotechnology annual return on equity?
The current annual ROE of VIR is -33.53%
What is the all time high annual ROE for Vir Biotechnology?
Vir Biotechnology all-time high annual return on equity is 101.36%
What is Vir Biotechnology annual ROE year-on-year change?
Over the past year, VIR annual return on equity has changed by -62.92% (-214.09%)
What is Vir Biotechnology quarterly return on equity?
The current quarterly ROE of VIR is -35.62%
What is the all time high quarterly ROE for Vir Biotechnology?
Vir Biotechnology all-time high quarterly return on equity is 703.88%
What is Vir Biotechnology quarterly ROE year-on-year change?
Over the past year, VIR quarterly return on equity has changed by -5.64% (-18.81%)